PLN 84.0
(0.0%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 162 Thousand PLN | 88.37% |
2022 | 86 Thousand PLN | 0.0% |
2021 | - PLN | -100.0% |
2020 | 690.7 Thousand PLN | 885988.52% |
2019 | 77.95 PLN | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 147 Thousand PLN | -9.26% |
2024 Q2 | -3.94 Million PLN | -100.0% |
2023 Q1 | 91 Thousand PLN | 5.81% |
2023 Q4 | 162 Thousand PLN | 305.0% |
2023 Q3 | 40 Thousand PLN | -57.45% |
2023 Q2 | 94 Thousand PLN | 3.3% |
2023 FY | 162 Thousand PLN | 88.37% |
2022 Q1 | 49.21 Thousand PLN | 583.6% |
2022 Q4 | 86 Thousand PLN | 0.0% |
2022 Q3 | - PLN | 100.0% |
2022 Q2 | -1000.00 PLN | -102.03% |
2022 FY | 86 Thousand PLN | 0.0% |
2021 Q1 | - PLN | 0.0% |
2021 FY | - PLN | -100.0% |
2021 Q4 | 7200.00 PLN | 359900.0% |
2021 Q3 | 2.00 PLN | 72.41% |
2021 Q2 | 1.16 PLN | 0.0% |
2020 FY | 690.7 Thousand PLN | 885988.52% |
2019 FY | 77.95 PLN | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Bioceltix S.A. | 8617.89 PLN | -1779.81% |
BIOTON S.A. | 117.91 Million PLN | 99.863% |
Captor Therapeutics Spolka Akcyjna | - PLN | -Infinity% |
Mabion S.A. | 6.84 Million PLN | 97.633% |
Molecure S.A. | - PLN | -Infinity% |
NanoGroup S.A. | 63.37 Thousand PLN | -155.609% |
Pharmena S.A. | 445 Thousand PLN | 63.596% |
Poltreg S.A. | 415 Thousand PLN | 60.964% |
Pure Biologics Spólka Akcyjna | 17.56 Million PLN | 99.078% |
Ryvu Therapeutics S.A. | 2.11 Million PLN | 92.351% |
Synthaverse S.A. | 15.48 Million PLN | 98.954% |